BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3102127)

  • 1. Action of a prostaglandin synthetase inhibitor on IUD associated uterine bleeding.
    Di Lieto A; Catalano D; Miranda L; Paladini A
    Clin Exp Obstet Gynecol; 1987; 14(1):41-4. PubMed ID: 3102127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of IUD related menorrhagia by indomethacin.
    Yarkoni S; Anteby SO
    Clin Exp Obstet Gynecol; 1984; 11(4):120-2. PubMed ID: 6437699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal intrauterine devices.
    Rybo G; Andersson K; Odlind V
    Ann Med; 1993 Apr; 25(2):143-7. PubMed ID: 8489751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of prostaglandins and allied substances in uterine haemostasis.
    Hagenfeldt K
    Contraception; 1987 Jul; 36(1):23-35. PubMed ID: 3311624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of plasminogen activator in human uterine tissue induced by intrauterine contraceptive devices.
    Shaw ST; Macaulay LK; Sun NC; Tanaka MS; Roche PC
    Contraception; 1983 Feb; 27(2):131-40. PubMed ID: 6682747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of prostaglandins in IUD-associated uterine bleeding--effect of a prostaglandin synthetase inhibitor (ibuprofen).
    Roy S; Shaw ST
    Obstet Gynecol; 1981 Jul; 58(1):101-6. PubMed ID: 7243136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can intrauterine device removals for bleeding or pain be predicted at a one-month follow-up visit? A multivariate analysis.
    Stanback J; Grimes D
    Contraception; 1998 Dec; 58(6):357-60. PubMed ID: 10095972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of abnormal bleeding in an intrauterine device user].
    Desmons F; Adam-steen C
    Cah Sexol Clin; 1985; 11(63):185-7. PubMed ID: 12281357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menstrual bleeding with copper-covered intrauterine contraceptive devices.
    Malmqvist R; Petersohn L; Bengtsson LP
    Contraception; 1974 Jun; 9(6):627-33. PubMed ID: 4448089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
    Luukkainen T; Toivonen J
    Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D; Schacht E
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative studies on menstrual blood loss in IUD users.
    Andrade AT; Pizarro Orchard E
    Contraception; 1987 Jul; 36(1):129-44. PubMed ID: 3311622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a prostaglandin synthetase inhibitor, indomethacin, on excessive uterine bleeding.
    Anteby SO; Yarkoni S; Ever Hadani P
    Clin Exp Obstet Gynecol; 1985; 12(3-4):60-3. PubMed ID: 4064305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices.
    Ylikorkala O; Viinikka L
    Br J Obstet Gynaecol; 1983 Jan; 90(1):78-83. PubMed ID: 6336951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menstrual blood loss, haemoglobin and ferritin concentration of Beijing women wearing steel ring, VCu 200, and TCu 220c IUDs.
    Gao J; Zeng S; Sun BL; Wu SC; Dong J; Cong J; Zhu XH; Fan HM; Han LH; Xie Z
    Contraception; 1986 Dec; 34(6):559-71. PubMed ID: 3829674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies in menorrhagia: (a) mefenamic acid, (b) endometrial prostaglandin concentrations.
    Haynes PJ; Flint AP; Hodgson H; Anderson AB; Dray F; Turnbull AC
    Int J Gynaecol Obstet; 1980; 17(6):567-72. PubMed ID: 6106574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device.
    Fedele L; Bianchi S; Raffaelli R; Portuese A; Dorta M
    Fertil Steril; 1997 Sep; 68(3):426-9. PubMed ID: 9314908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levonorgestrel intrauterine device in the treatment of menorrhagia in Chinese women: efficacy versus acceptability.
    Tang GW; Lo SS
    Contraception; 1995 Apr; 51(4):231-5. PubMed ID: 7796588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunctional uterine bleeding in ovulatory women.
    Strickler RC
    Postgrad Med; 1985 Jan; 77(1):235-7, 240-3, 246. PubMed ID: 3880890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of increased menstrual blood loss in IUD users.
    Toppozada M
    Contraception; 1987 Jul; 36(1):145-57. PubMed ID: 3311623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.